Get the Stockscreener App
55.43
1.41%
-0.79
After Hours:
55.43
Livanova Plc stock is traded at $55.43, with a volume of 428.79K.
It is down -1.41% in the last 24 hours and up +3.18% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$56.22
Open:
$56.16
24h Volume:
428.79K
Relative Volume:
0.67
Market Cap:
$3.03B
Revenue:
$1.28B
Net Income/Loss:
$-222.15M
P/E Ratio:
-13.55
EPS:
-4.09
Net Cash Flow:
$145.52M
1W Performance:
-4.96%
1M Performance:
+3.18%
6M Performance:
+41.26%
1Y Performance:
+14.22%
1-Day Range:
$55.12
$56.44
1-Week Range:
$55.12
$58.91
52-Week Range:
$32.48
$58.91
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
55.43 | 3.07B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
131.33 | 232.75B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
99.87 | 152.19B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
377.11 | 146.55B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.43 | 120.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
76.05 | 45.54B | 5.69B | 1.41B | 577.90M | 6.95 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
Petrus Trust Company LTA Sells 7,789 Shares of LivaNova PLC $LIVN - MarketBeat
LivaNova (NASDAQ:LIVN) Sets New 1-Year HighHere's What Happened - MarketBeat
LivaNova PLC $LIVN Shares Sold by Great Lakes Advisors LLC - MarketBeat
Bayforest Capital Ltd Makes New $590,000 Investment in LivaNova PLC $LIVN - MarketBeat
EP Wealth Advisors LLC Takes Position in LivaNova PLC $LIVN - MarketBeat
Clearline Capital LP Makes New Investment in LivaNova PLC $LIVN - MarketBeat
Aristeia Capital L.L.C. Sells 9,800 Shares of LivaNova PLC $LIVN - MarketBeat
Amundi Grows Stock Position in LivaNova PLC $LIVN - MarketBeat
Millennium Management LLC Sells 993,663 Shares of LivaNova PLC $LIVN - MarketBeat
LivaNova PLC $LIVN Shares Purchased by AQR Capital Management LLC - MarketBeat
LivaNova at Morgan Stanley Conference: Expanding Neuromodulation Horizons - Investing.com
LivaNova at Baird Global Healthcare Conference: Strategic Growth Insights - Investing.com
Needham & Company LLC Reiterates Buy Rating for LivaNova (NASDAQ:LIVN) - MarketBeat
RSI + MACD Show Convergence for LivaNova PLCJuly 2025 Snapshot & Weekly Return Optimization Plans - beatles.ru
LivaNova PLC (LIVN) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
LivaNova PLC $LIVN Shares Sold by Parkman Healthcare Partners LLC - MarketBeat
Cubist Systematic Strategies LLC Acquires 78,830 Shares of LivaNova PLC $LIVN - MarketBeat
LivaNova PLC stock trend outlook and recovery pathInsider Selling & Community Consensus Trade Alerts - Newser
LivaNova PLC $LIVN Shares Purchased by Maverick Capital Ltd. - MarketBeat
what moving averages say about livanova plcStock Surge & Safe Entry Momentum Tips - Newser
What institutional flow reveals about LivaNova PLC2025 Top Decliners & Technical Pattern Recognition Alerts - Newser
Panagora Asset Management Inc. Increases Stake in LivaNova PLC $LIVN - MarketBeat
What are LivaNova PLC’s recent SEC filings showingQuarterly Growth Report & Step-by-Step Trade Execution Guides - خودرو بانک
Is LivaNova PLC a cyclical or defensive stockJuly 2025 Update & Long-Term Safe Investment Ideas - خودرو بانک
LivaNova stock hits 52-week high at 57.52 USD By Investing.com - Investing.com Australia
Is LivaNova PLC a top pick in the sectorJuly 2025 Volume & Verified Stock Trade Ideas - خودرو بانک
What’s the RSI of LivaNova PLC stockMarket Performance Summary & Free Verified High Yield Trade Plans - خودرو بانک
LivaNova appoints Don Zurbay to board of directors By Investing.com - Investing.com Nigeria
Multi factor analysis applied to LivaNova PLCEarnings Recap Report & Low Drawdown Investment Ideas - Newser
LivaNova Appoints Donald Zurbay as a New Director - BioSpace
Northern Trust Corp Sells 9,670 Shares of LivaNova PLC $LIVN - MarketBeat
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):